BridgeMD
New treatment option for Speech Sound Disorder
Official title BiOfeedback, Online for Sibilant Treatment
ClinicalTrials.gov ID: NCT07041723
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate the efficacy of sibilant biofeedback treatment delivered via telepractice in six children ages 8:0-17;11 who present with distortions of /s/. The main questions it aims to answer are: Primary hypothesis: Biofeedback treatment for sibilants delivered via telepractice will produce positive gains compared to a no-treatment baseline phase.
- Time commitment: about 10 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 17
You may be able to join if
- Age between 8;0 and 17;11 years at the time of enrollment
- English as the dominant language (must have begun learning English by age 3, per parent report)
- Passes pure-tone hearing screening at 30 dB hearing level
- Passes brief examination of oral structure and function
- Less than 30% accuracy, based on consensus across 2 trained listeners, on a probe list eliciting fricative /s, z/ in various phonetic contexts at the...
You likely can't join if
- Scaled score of 7 or higher on the Recalling Sentences and Formulated Sentences subtests of the Clinical Evaluation of Language Fundamentals-5...
- History of permanent hearing loss (temporary hearing loss due to otitis media, including recurrent OM/tubes, is admissible)
- History of developmental disorder (e.g., Down syndrome, cerebral palsy)
- History of major brain injury, surgery, or stroke in the past year (mild concussion is admissible)
- Active diagnosis of epilepsy or other neurological disorder (permissible if well-controlled for at least 6 months)
- Current diagnosis of voice or fluency disorder
See the full eligibility criteria
- Age between 8;0 and 17;11 years at the time of enrollment
- English as the dominant language (must have begun learning English by age 3, per parent report)
- Passes pure-tone hearing screening at 30 dB hearing level
- Passes brief examination of oral structure and function
- Less than 30% accuracy, based on consensus across 2 trained listeners, on a probe list eliciting fricative /s, z/ in various phonetic contexts at the word level
- No more than 3 sounds other than /s/ in error on the Goldman-Fristoe Test of Articulation-3 (GFTA-3)
- Diagnosis of ADHD, learning disability, dyslexia, or neurodiversity is admissible if participant meets cutoff scores on evaluation day 1
- History of CAS is admissible if participant meets cutoff scores on evaluation day 1
- Braces and removable retainers are admissible
- Access to a laptop or desktop computer and a quiet space for study sessions
- Scaled score of 7 or higher on the Recalling Sentences and Formulated Sentences subtests of the Clinical Evaluation of Language Fundamentals-5 (CELF-5)
- History of permanent hearing loss (temporary hearing loss due to otitis media, including recurrent OM/tubes, is admissible)
- History of developmental disorder (e.g., Down syndrome, cerebral palsy)
- History of major brain injury, surgery, or stroke in the past year (mild concussion is admissible)
- Active diagnosis of epilepsy or other neurological disorder (permissible if well-controlled for at least 6 months)
- Current diagnosis of voice or fluency disorder
- Current presence of orthodontia that crosses the palate (braces and removable retainers are admissible)
- Lack of access to a laptop or desktop computer and a quiet space for study sessions
The study team makes the final eligibility decision.
Where it's taking place
- Bloomfield, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bloomfield, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.